MarketResearchReports.Biz announces addition of new report “Gastrointestinal Therapeutics In Asia-Pacific Markets To 2019” to its database.

Albany, NY -- (ReleaseWire) -- 01/29/2014 --GBI Research, the leading business intelligence provider, has released its latest research, "Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 – Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need", which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the therapeutic indications of gastrointestinal disorders, namely Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three gastrointestinal indications.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/gastrointestinal-therapeutics-in-asia-pacific-markets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-need

Scope
Disease overview and treatment usage patterns
Market size and forecast for IBS, UC and CD in APAC market from 2012 to 2019
Major marketed products for the indications types covered
In-depth pipeline analysis for IBS, UC and CD
Key drivers and restraints that have had and are expected to have a significant impact upon the market

To Get Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/185777

Reasons to Buy
The report will enhance your decision-making capability by allowing you to:

Align your product portfolio to the markets with high growth potential
Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the gastrointestinal therapeutics market
Develop key strategic initiatives based upon an understanding of key focus areas and leading companies

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

To Read Complete Report With TOC: http://www.marketresearchreports.biz/analysis/185777

2 Gastrointestinal Therapeutics in Asia-Pacific Market – Introduction
2.1 Irritable Bowel Syndrome
2.1.1 Classification
2.1.2 Symptoms
2.1.3 Etiology
2.1.4 Pathophysiology
2.1.5 Diagnosis
2.1.6 Epidemiology
2.1.7 Prognosis
2.1.8 Treatment Options
2.2 Ulcerative Colitis
2.2.1 Classification

3 Gastrointestinal Therapeutics in Asia-Pacific Market – Marketed Products (Global)
3.1 Irritable Bowel Syndrome
3.2 Ulcerative Colitis
3.3 Crohn’s Disease
3.4 Key Marketed Products
3.4.1 Amitiza
3.4.2 Humira
3.4.3 Remicade

About MarketResearchReports
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one-stop solution for all your research needs; our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
Blog: http://allbusinessresearch.blogspot.com/